| Literature DB >> 28832653 |
Yi-Chun Tsai1,2, Hui-Mei Chen3,4, Shih-Ming Hsiao5, Cheng-Sheng Chen3,6, Ming-Yen Lin2,7, Yi-Wen Chiu2,7, Shang-Jyh Hwang2,7, Mei-Chuan Kuo2,7.
Abstract
Patients with chronic kidney disease (CKD) are more readily prone to have impaired physical activity than the general population. The aim of this study is to examine the relationship between physical activity and adverse clinical outcomes and quality of life (QOL) in CKD. One hundred and sixty-one patients with CKD stages 1-5 was enrolled from February 2013 to September 2013 and followed up until June 2016. Physical activity was measured using high handgrip strength, 30-second chair stand, and 2-minute step. The QOL was assessed using the Taiwan version of the World Health Organization Quality of Life-BREF. Clinical outcomes included commencing dialysis, major adverse cardiovascular events (MACEs), and first hospitalization. Of all participants, 1 kgf increase in handgrip strength was significantly associated with 0.13 score increase in total scores of QOL and 0.05 score increase in physical domain of QOL in adjusted analysis. One time increase in 30-second chair stand was significantly correlated with 0.14 score increase in psychological domain of QOL. Over a mean follow-up period of 29.1±11.2 months, 37 (23.0%) reached commencing dialysis, 11(6.8%) had MACEs, and 50(31.1%) had first hospitalization. High handgrip strength (hazard ratio (HR): 0.89, 95% CI: 0.84-0.96) and high 2-minute step (HR: 0.04, 95% CI: 0.01-0.95) were significantly associated with decreased risk for commencing dialysis in multivariate analysis. Thirty-second chair-stand was negatively associated with MACEs (HR: 0.65, 95%CI: 0.47-0.89) and first hospitalization (HR: 0.84, 95%CI: 0.74-0.95). In conclusion, physical activity is a potential predictor of QOL and adverse clinical outcomes in patients with CKD.Entities:
Mesh:
Year: 2017 PMID: 28832653 PMCID: PMC5568323 DOI: 10.1371/journal.pone.0183642
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The clinical characteristics of study subjects stratified by CKD stages.
| Entire Cohort | CKD stage 1–3 | CKD stage 4–5 | P-value | |
|---|---|---|---|---|
| Demographic variables | ||||
| Age, year | 67.2±7.8 | 67.7±7.8 | 66.8±7.8 | 0.48 |
| Sex (male), n% | 87(54.0) | 38(58.5) | 49(51.0) | 0.35 |
| Smoke (yes), n% | 46(28.6) | 19(29.2) | 27(28.1) | 0.87 |
| Alcohol (yes), n% | 29(18.0) | 12(18.5) | 17(17.7) | 0.90 |
| Marriage (yes), n% | 132(82.0) | 53(81.5) | 79(82.3) | 0.90 |
| Religion (yes), n% | 135(90.0) | 53(86.9) | 82(92.1) | 0.29 |
| Occupation (yes), n% | 50(31.1) | 17(26.2) | 33(34.4) | 0.26 |
| Education | ||||
| (senior high school or above) | 83(51.6) | 38(58.5) | 45(46.9) | 0.15 |
| Cardiovascular disease (yes), n% | 24(15.0) | 6(9.2) | 18(18.9) | 0.09 |
| Diabetes (yes), n% | 60(37.3) | 18(27.7) | 42(43.8) | 0.04 |
| Hypertension (yes), n% | 114(70.8) | 37(56.9) | 77(80.2) | 0.001 |
| Hyperlipidemia (yes), n% | 66(41.0) | 20(30.8) | 46(47.9) | 0.03 |
| Gout (yes), n% | 28(17.4) | 10(15.4) | 18(18.8) | 0.58 |
| Body Mass Index, kg/m2 | 24.4±3.8 | 24.4±4.0 | 24.3±3.8 | 0.82 |
| Physical activity | ||||
| 2-minute step | 105(92,115) | 106(94,120) | 104(90,112) | 0.16 |
| Handgrip strength, kgf | 26.9±7.7 | 28.0±7.5 | 26.1±7.8 | 0.12 |
| 30-second chair stand | 11.2±3.1 | 11.9±3.5 | 10.7±2.8 | 0.02 |
| Questionnaires of exercise capacity | 0.005 | |||
| No exercise (yes), n% | 8(5.0) | 2(3.1) | 6(6.3) | |
| Low activity (yes), n% | 113(70.2) | 45(69.2) | 68(70.8) | |
| Middle+High activity (yes), n% | 40(24.8) | 21(32.3) | 19(19.8) | |
| Medications | ||||
| β-blocker (yes), n% | 28(17.4) | 9(13.8) | 19(19.8) | 0.32 |
| Calcium channel blocker (yes), n% | 69(42.9) | 15(23.1) | 54(56.3) | <0.001 |
| ACEI/ARB (yes), n% | 52(32.3) | 10(15.4) | 42(43.8) | <0.001 |
| Lipitor (yes), n% | 33(20.5) | 10(15.4) | 23(24.0) | 0.18 |
| Quality of life | ||||
| Total score | 52.3±5.3 | 53.2±5.2 | 51.4±5.2 | 0.03 |
| Physical domain | 11.9±1.5 | 12.1±1.5 | 11.7±1.5 | 0.14 |
| Psychological domain | 12.6±1.7 | 12.8±1.7 | 12.3±1.7 | 0.05 |
| Social domain | 13.2±2.0 | 13.5±2.1 | 12.9±2.0 | 0.05 |
| Environment domain | 14.7±1.5 | 14.8±1.5 | 14.6±1.4 | 0.25 |
| Laboratory parameters | ||||
| Blood urea nitrogen, mg/dl | 33.5(21.4,55.3) | 19.7(14.7,23.8) | 48.4(34.2,65.3) | <0.001 |
| Creatinine, mg/dl | 3.1±2.4 | 1.2±0.5 | 4.3±2.3 | <0.001 |
| eGFR, ml/min/1.73m2 | 34.5±28.8 | 62.2±26.1 | 15.7±7.7 | <0.001 |
| Hemoglobin, g/dl | 11.0±2.0 | 12.5±1.8 | 10.5±1.8 | <0.001 |
| Albumin, g/dl | 4.2±0.3 | 4.3±0.4 | 4.2±0.4 | 0.18 |
| Phosphate, mg/dl | 4.1(3.5,4.6) | 3.6(3.2,3.9) | 4.3(3.9,4.8) | <0.001 |
| Calcium, meq/L | 9.1±0.6 | 9.3±0.4 | 9.0±0.6 | 0.03 |
| Sodium, meq/L | 139.0±2.6 | 139.7±2.0 | 138.6±2.8 | 0.01 |
| Potassium, meq/L | 4.2±0.5 | 4.1±0.4 | 4.3±0.5 | 0.001 |
| Cholesterol, mg/dl | 185.9±35.6 | 186.5±32.7 | 185.4±37.7 | 0.84 |
| Triglyceride, mg/dl | 117.0(82.0,159.0) | 115.1(81.0,144.5) | 120.0(81.5,167.0) | 0.23 |
| Urine protein-creatinine ratio, g/g | 0.8(0.3,1.6) | 0.2(0.1,0.5) | 1.0(0.5,1.7) | <0.001 |
Notes: Data are expressed as number (percentage) for categorical variables and mean±SD or median (25th, 75th percentile) for continuous variables, as appropriate.
Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate
Linear regression analysis of association of physical activity with quality of life in patients with chronic kidney disease.
| 2-minute step | Handgrip strength, kgf | 30-second chair-stand | ||||
|---|---|---|---|---|---|---|
| Univariate | multivariate | Univariate | multivariate | Univariate | multivariate | |
| Total scores | 7.08(-0.65,14.81) | -0.39(-9.33,8.56) | 0.17(0.06,0.27) | 0.13(0.01,0.24) | 0.30(0.04,0.55) | 0.04(-0.05,0.13) |
| Physical domain | 2.21(-0.03,4.46) | 0.68(-1.89,3.24) | 0.05(0.02,0.08) | 0.05(0.02–0.08) | 0.08(0.01,0.15) | 0.04(-0.05,0.13) |
| Psychological domain | 1.76(-0.80,4.32) | 0.56(-2.60,3.72) | 0.03(-0.00,0.06) | 0.04(-0.02,0.09) | 0.13(0.04,0.21) | 0.14(0.05,0.24) |
| Social domain | 1.83(-1.17,4.85) | 0.51(-2.84,3.86) | 0.05(0.01,0.08) | 0.04(-0.03,0.09) | 0.11(0.01,0.21) | 0.07(-0.04,0.18) |
| Environmental domain | 1.26(-0.87,3.40) | -0.01(-2.43,2.41) | 0.04(0.01,0.06) | 0.04(-0.02,0.10) | -0.02(-0.09,0.05) | -0.05(-0.13,0.03) |
Multivariate linear regression analysis was adjusted for all variables of p-value<0.05 plus age, sex, and serum creatinine level
*Log-formed 2-minute step
aP<0.01
bP<0.05
Clinical outcomes of CKD patients stratified by CKD stages.
| Entire cohort (n = 161) | CKD stage 1–3 | CKD stage 4–5 | P-value | |
|---|---|---|---|---|
| Follow-up period, months | 29.1±11.2 | 31.4±8.6 | 27.5±12.4 | 0.02 |
| Commencing dialysis, n(%) | 37(23.0) | 1(1.5) | 36(37.5) | <0.001 |
| Major adverse | 11(6.8) | 1(1.5) | 10(10.4) | 0.02 |
| All-causes hospitalization, n(%) | 50(31.1) | 17(26.2) | 33(34.4) | 0.26 |
Data are expressed as number (percentage) for categorical variables and mean±SD or median (25th, 75th percentile) for continuous variables, as appropriate.
Fig 1The cumulative probability of (A) commencing dialysis (B) major adverse cardiovascular events (MACE) (C) first hospitalization according to physical activity. The median of 2-minute step, handgrip strength, and 30-second chair stand was 105, 26.4kgf, and 11 respectively.
The adjusted risks for commencing dialysis, major adverse cardiovascular events (MACEs), and all causes hospitalization according to physical function.
| Commencing dialysis | MACEs | All causes hospitalization | ||||
|---|---|---|---|---|---|---|
| Hazard ratio | P-value | Hazard ratio | P-value | Hazard ratio | P-value | |
| 2-minute step | 0.04(0.01–0.95) | 0.04 | 0.04(0.00–30.05) | 0.33 | 0.94(0.04–22.51) | 0.97 |
| handgrip strength, kgf | 0.89(0.84–0.96) | 0.005 | 0.99 (0.87–1.13) | 0.94 | 0.96(0.90–1.02) | 0.17 |
| 30-second chair-stand | 1.02(0.88–1.17) | 0.82 | 0.65(0.47–0.89) | 0.008 | 0.84(0.74–0.95) | 0.01 |
Abbreviations: CI, Confidence Interval
Adjusted model: age, sex, cardiovascular disease, diabetes mellitus, angiotensin converting enzyme inhibitor/angiotensin II receptor blocker usage, urine protein-creatinine ratio cut at 1mg/mg, and serum creatinine, albumin and hemoglobin level
Fig 2Adjusted hazard ratios (HRs) of commencing dialysis for handgrip strength in all chronic kidney disease patients stratified by age, sex, and serum albumin level.
Ratios were adjusted for age, sex, creatinine. The median of serum albumin was 4.2 g/dl. 95% CI, 95% confidence intervals.